Skip to main content
Equibles

Amy Vandekop

Chief Accounting Officer

Kalaris Therapeutics, Inc. (KLRS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Amy Vandekop

Amy Vandekop is recorded as Chief Accounting Officer at Kalaris Therapeutics, Inc. (KLRS). Kalaris Therapeutics, Inc. reported in an 8-K filed July 20, 2026 that Amy Vandekop was appointed interim principal accounting officer, effective July 27, 2026.

“As a result, on July 16, 2026, the Board designated Amy Vandekop, the Company’s Corporate Controller, as the Company’s interim principal accounting officer, effective as of July 27, 2026.”
Kalaris Therapeutics, Inc. Form 8-K, filed July 20, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Kalaris Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.